Research study Program year 2021 Source: CMS Open Payments

COS High Spiking

Research payments

$258,169

5 payments

Through program year 2021, $258,169 in research payments was reported against COS High Spiking, across 5 payments, paid by Becton, Dickinson and Company.

Paid by: Becton, Dickinson and Company
ClinicalTrials.gov: No trial number was reported for this study

By program year

2 rows

Year	Kind	Amount	Payments
2021	Research	$256,420	4
2020	Research	$1,749	1

Breakdown

Who paid Research payments · program years 2020–2021

Becton, Dickinson and Company $258,169 5 payments

Who received the money Research payments · program years 2020–2021

Tkl Research Organisation paid for research $250,427 2 payments
Igor Genkin Hematology & Oncology · Salem, OH $3,150 1 payment
Michael Casser Internal Medicine · New Milford, NJ $2,844 1 payment
TKL Research Inc. Organisation paid for research $1,749 1 payment

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

1 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

Igor Genkin Hackettstown, NJ Named on 3 payments

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.